
AI Drug Firm Raises $5bn to Push Candidates
Isomorphic Labs, a DeepMind spinout, plans to advance AI-designed cancer and immune treatments toward clinical trials; the candidates remain pre-clinical.
Live Poll
Do you trust AI to help develop safe new medicines?